Review of invertebrate biological control agent regulation in Australia, New Zealand, Canada and the USA: recommendations for a harmonized European system

Emma J. Hunt, U. Kuhlmann, A. W. Sheppard, Tianyu Qin, B.I.P. Barratt, L. Harrison, Peter G. Mason, David Parker, R. V. Flanders, John A. Goolsby

Journal of Applied Entomology · 2007 · 72 citations · 17 references

Concepts

TL;DR

Europe lags behind Australia, New Zealand, Canada and the USA in implementing regulatory procedures for invertebrate biological control agents, despite recent guidelines, with few member states adopting them due to concerns about cost and complexity, yet the experience of these countries offers potential benefits. The paper aims to formulate a regulatory system for Europe that is readily approved and adopted by all member countries, proposing recommendations drawn from successful features of the four countries’ processes. The authors review the regulatory processes in Australia, New Zealand, Canada and the USA and use these analyses to propose recommendations for a harmonized European system.

Abstract

Abstract Europe lags far behind Australia, New Zealand, Canada and the USA in terms of implementing regulatory procedures for the import and release of invertebrate biological control agents (IBCAs). A number of standards, documents and guidelines have been produced over recent years in an attempt to harmonize regulation of IBCA introduction into Europe. Despite these efforts, the number of member countries implementing any form of IBCA regulation remains low, with many industries, biological practitioners and regulators fearing that a regulatory system would render the process of approval for IBCA introduction into a country costly and time consuming. Europe’s priority is therefore to formulate a regulatory system that will be readily approved of and adopted by all member countries. In this paper we review the current regulatory processes operating in Australia, New Zealand, Canada and the USA. There is potential for Europe to benefit from the years of experience that these countries have in IBCA regulation. We therefore propose recommendations based on features of the regulatory processes in each of the four countries that work well and that could be adopted to generate a workable Europe‐wide regulatory system.

References

17